Severe traumatic brain injury in children is a significant concern because of its high morbidity and mortality rates. Pediatric patients pose unique challenges in the management of TBI because of anatomical and physiological differences from adults. This article discusses the pathophysiology, assessment, acute management, neurocritical care, rehabilitation strategies, and emerging treatments in pediatric severe TBI. Early intervention, including airway management, intracranial pressure (ICP) monitoring, and neuroprotective strategies, is crucial in improving outcomes. Multidisciplinary care and long-term rehabilitation play pivotal roles in optimizing recovery and quality of life for affected children. Advances in neuroimaging, biomarker research, and personalized medicine are shaping the future of pediatric TBI management.
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in children, with severe cases requiring prompt and specialized management. Unlike adults, pediatric patients have unique anatomical, physiological, and developmental considerations that influence their response to injury and treatment. The developing brain is more vulnerable to secondary injuries, and improper management can lead to long-term neurocognitive impairments. This article discusses the detailed management of severe TBI in children, including state-of-the-art evidence-based practice and promising research developments.
Severe TBI results from external forces causing brain tissue damage, leading to primary and secondary injuries:
Primary Injury: Occurs at the moment of impact and includes skull fractures, contusions, and diffuse axonal injury.
Secondary Injury: This develops over time due to cerebral edema, hypoxia, ischemia, inflammation, and metabolic dysfunction.
Pediatric brains have higher water content, leading to increased susceptibility to swelling, which can result in elevated intracranial pressure (ICP) and cerebral herniation if not managed promptly.
A structured approach is essential for the early assessment of severe pediatric TBI:
Primary Survey (ABCDEs): Ensuring airway patency, adequate breathing, and circulation is the first priority. Early intubation may be required for airway protection.
Glasgow Coma Scale (GCS) Adaptation for Pediatrics: A GCS score of 8 or lower defines severe TBI.
Neuroimaging: Computed tomography (CT) scans are the gold standard for initial evaluation, while magnetic resonance imaging (MRI) is useful for assessing diffuse axonal injury and brainstem involvement.
Monitoring: Continuous assessment of neurological status, oxygenation, and hemodynamics is essential for early intervention.
Early and aggressive management is crucial to prevent secondary brain injury:
Airway and Ventilation:
Endotracheal intubation and mechanical ventilation are required for patients with compromised airways or low GCS.
Targeting normoxia and normocapnia (PaCO2 35-40 mmHg) is essential to prevent hypoxia-induced secondary injury.
Intracranial Pressure (ICP) and Cerebral Perfusion Pressure (CPP) Management:
Maintain ICP < 20 mmHg and CPP between 40-50 mmHg for optimal cerebral perfusion.
Hyperosmolar therapy (mannitol or hypertonic saline) is used to control ICP.
External ventricular drains (EVDs) may be required for CSF diversion and ICP monitoring.
Blood Pressure and Fluid Management:
Hypotension should be aggressively managed with isotonic fluids to maintain cerebral perfusion.
Avoid hypotonic solutions to reduce the risk of cerebral edema.
Temperature and Glycemic Control:
Avoid fever, as hyperthermia exacerbates brain injury.
Maintain normoglycemia, avoiding both hyperglycemia and hypoglycemia.
Seizure Prevention and Neuroprotection:
Prophylactic antiepileptic drugs (e.g., levetiracetam) may be considered for high-risk patients.
Sedation and analgesia (e.g., propofol, fentanyl) reduce metabolic demand and agitation.
Severe TBI requires intensive care unit (ICU) management, including:
Continuous EEG Monitoring: Helps detect subclinical seizures.
Neuroimaging Follow-Up: Serial CT/MRI scans assess the progression or resolution of injuries.
Rehabilitation Planning: Early mobilization, speech therapy, and cognitive rehabilitation improve long-term outcomes.
Pediatric severe TBI survivors often face long-term neurological and cognitive impairments. Rehabilitation is essential for recovery and includes:
Physical Therapy: Focuses on motor function recovery and mobility.
Occupational Therapy: Helps regain daily living skills and independence.
Cognitive and Behavioral Therapy: Addresses learning difficulties, memory deficits, and emotional changes.
Multidisciplinary Approach: Pediatric neurologists, rehabilitation specialists, and psychologists work together to enhance recovery.
Advancements in TBI management aim to improve outcomes through:
Neuroimaging Innovations: Diffusion tensor imaging (DTI) and functional MRI provide insights into brain connectivity and recovery potential.
Biomarker Research: Identifying biomarkers for early TBI diagnosis and prognosis.
Regenerative Medicine: Stem cell therapy and neuroprotective agents show promise in enhancing brain repair.
Artificial Intelligence in TBI Care: AI-assisted imaging interpretation and predictive modeling aid in decision-making and personalized treatment plans.
Pediatric patients with severe traumatic brain injury continue to pose a significant health challenge. Improving survival and functional outcomes involves early and aggressive intervention, such as airway management, control of intracranial pressure, and neurocritical care. Rehabilitation and long-term follow-up are also very important for the optimization of recovery and quality of life. Continued research into neuroimaging, biomarkers, and regenerative medicine holds the promise of revolutionizing the management of TBI in children. A multidisciplinary, patient-centered approach will continue to be the cornerstone of pediatric TBI care, ensuring the best possible outcomes for affected children and their families.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation